Atlas Trials

Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants

Clinical trial NCT07443436 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07443436
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Interstitial Lung Disease
Start date
2026-10-01
Primary completion
2027-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.